BetterScholar BetterScholar
17
Title Level Year L/Y
Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage.
N. Ercal, H. Gurer-Orhan, N. Aykin-Burns
10 2001 10
2001
Drug discovery today.
O. Schwardt, H. Kolb, B. Ernst
10 2003 10
2003
Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry.
M. Feng, Bingqing Tang, Steven H. Liang, Xuefeng Jiang
10 2016 10
2016
Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger.
10 auth. D. Tan, R. Reiter, L. Manchester, Mei-ting Yan, M. El-Sawi, R. Sainz, ... J. Mayo, R. Kohen, M. Allegra, R. Hardeland
9 2002 9
2002
Subunit composition, distribution and function of GABA(A) receptor subtypes.
W. Sieghart, G. Sperk
9 2002 9
2002
Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery.
S. Vilar, G. Cozza, S. Moro
9 2008 9
2008
Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
E. Lionta, G. Spyrou, D. Vassilatis, Z. Cournia
9 2014 9
2014
Surface chemistry influences implant biocompatibility.
P. Thevenot, Wenjing Hu, Liping Tang
9 2008 9
2008
3D-QSAR in drug design--a review.
Jitender Verma, V. Khedkar, E. Coutinho
9 2010 9
2010
Mechanisms of action of antiepileptic drugs.
P. Czapiński, B. Błaszczyk, S. Czuczwar
9 2005 9
2005
Oxytosis: A novel form of programmed cell death.
Shirlee Tan, D. Schubert, P. Maher
8 2001 8
2001
Melatonin-immune system relationships.
J. Guerrero, R. Reiter
8 2002 8
2002
The significance of chirality in drug design and development.
W. Brooks, W. Guida, K. Daniel
8 2011 8
2011
Ruthenium antimetastatic agents.
E. Alessio, G. Mestroni, A. Bergamo, G. Sava
8 2004 8
2004
Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy.
D. Blask, L. Sauer, R. Dauchy
8 2002 8
2002
Role of flavonoids in oxidative stress.
N. Cotelle
8 2001 8
2001
Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity--targets--functions.
A. Galat
8 2003 8
2003